Skip to content
Open access

Sex differences and gender-related factors in the management and perception of LDL-cholesterol in ASCVD: Real-Life evidence from the EPHESUS registry in cardiology practice

Sep 2026 · Atherosclerosis Plus · Vol 65 · 0 citations · 37 references
Medicine

TL;DR

Age and education accounted for a substantial part of the observed differences between women and men in ASCVD care, whereas lower statin prescription in women persisted after matching, whereas cardiometabolic covariates remained imbalanced by design.

Abstract

Aims Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of morbidity and mortality globally. While it impacts both sexes, women are frequently underdiagnosed and undertreated, particularly in lipid management. This study aimed to evaluate sex differences, and the gender-related factors potentially underlying them, in lipid control, the utilization of lipid-lowering therapy (LLT), and related perceptions within a large real-world cohort. Methods We analyzed 1482 patients with established ASCVD from the nationwide, multicenter EPHESUS registry, conducted in 40 cardiology outpatient clinics across Turkey. Differences between women and men in risk profiles, LLT use, low density lipoprotein-cholesterol (LDL-C) goal attainment, and perceptions from both patients and physicians were assessed. Women and men were compared before and after 1:1 propensity score matching for age and education; covariate balance was quantified with standardized mean differences (SMD). Results Women showed a greater burden of cardiometabolic conditions such as hypertension, diabetes, and obesity, yet were less often prescribed statins. Total cholesterol, HDL-C, non-HDL-C and on-treatment LDL-C were higher in women than in men, whereas triglycerides were similar between the sexes; on-treatment LDL-C was significantly higher in women (115 mg/dL vs. 100 mg/dL, p < 0.001). Women also met LDL-C targets less frequently according to the 2016 ESC/EAS guidelines (14.9% vs. 19.6%, p = 0.017), while the difference for the 2019 target was not significant (6.3% vs. 8.3%, p = 0.186). After matching, 924 patients (462 women and 462 men) remained; age and education were well balanced (SMD < 0.05), whereas cardiometabolic covariates remained imbalanced by design. Differences in lipid levels were no longer apparent, and among patients receiving high-intensity statins women more frequently achieved the 2016 LDL-C target (26.0% vs. 13.6%, p = 0.017), whereas the corresponding difference for the 2019 target did not reach statistical significance (10.7% vs. 4.5%, p = 0.072). Media influence was the most common physician-reported reason for LLT cessation; side effects and physician-advised discontinuation were reported more often for women, although these differences were not statistically significant. Conclusion Age and education accounted for a substantial part of the observed differences between women and men in ASCVD care, whereas lower statin prescription in women persisted after matching. Studies addressing sex differences should incorporate gender-related demographic factors into their design and analysis.

Read PDF

Similar papers

Oct 2026

A-003 Cardiovascular risk factors in patients with DM2; differences by gender.

Type 2 diabetes mellitus (T2DM) significantly increases cardiovascular risk (CVR). However, the burden of cardiovascular risk factors (CVRFs) and their clinical impact vary critically according to sex, requiring differentiated diagnostic approaches in laboratory medicine. The objective of this study was to evalua...

Eric Barlandas-Rendón, Gloria Abigail Pelaez-Rosas, S. Quintana-Ponce et al. · 0 citations
Open access Aug 2026

Patterns in Cardiovascular Risk Factors Stratified by Age and Sex in a Large German Population

Background Despite growing evidence of sex-specific differences in cardiovascular (CV) disease, sex-specific prevention strategies are lacking. Objectives This study aims to examine CV risk factors according to age and sex in a German working population. Methods In collaboration with ias PREVENT, a provider of medical...

J. Lueg, Daniel Schulze, Henrike Radefeld et al. · 0 citations
Oct 2026

A-001 Structural Relationship Between Non–HDL Cholesterol and the Total Cholesterol/HDL Ratio Across Sexes: Implications for Cardiovascular Risk Stratification in Chile

Cardiovascular disease (CVD) remains the leading cause of mortality in Chile, a middle-income country characterized by high prevalence of obesity, insulin resistance, and hypertriglyceridemia. In this metabolic context, non–high-density lipoprotein cholesterol (non-HDL-C) and the total cholesterol/HDL cholesterol...

J. Aldunate, M. Vial, Esteban Barnafi et al. · 0 citations
Open access Sep 2026

Layered Effects of LDL‐C Burden and Variability on Cardiovascular Events and Mortality in Type 2 Diabetes: A Nationwide Cohort Study

In T2DM, LDL-C burden and variability jointly identified patients at greater risk, especially for MI and cardiovascular mortality, especially in younger adults or longer-duration diabetes subgroups.

Dae-Jeong Koo, J. Park, Kyungdo Han et al. · 0 citations
Open access Aug 2026

Sex-based differences in glycaemic variability and clinical outcomes among older inpatients with type 2 diabetes: insights from the GLIMPACT study

Glycaemic variability (GV) has emerged as a potential marker of adverse outcomes in hospitalised patients with diabetes, yet its clinical impact in older adults and the role of sex differences remain unclear. To evaluate the association between in-hospital GV and length of stay (LOS) and one- and two-year...

Nicola Confortin, C. Ceolin, M. Vergadoro et al. · 0 citations
Open access Sep 2026

Sex-specific differences in acute coronary syndrome management and outcomes: How age and treatment gaps mask a female survival advantage.

BACKGROUND AND AIMS This nationwide registry study examined sex-specific differences in acute coronary syndrome management and all-cause mortality in Hungary between 2014 and 2024. METHODS Data from 184,616 patients in the Hungarian National Myocardial Infarction Register were analyzed. Median follow-up was 3.1 years...

C. Sári, Orsolya Bárdos-Csenteri, Péter Takács et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.